About CPC diagnostics
CPC diagnostics is a company based in Chennai (India) founded in 1987. CPC diagnostics has raised $9.27 million across 3 funding rounds from investors including Everlife Asia. The company has 287 employees as of April 06, 2024. CPC diagnostics offers products and services including Biochemistry Products, Haematology Analyzer, and Immunology Products. CPC diagnostics operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
- Headquarter Chennai, India
- Employees 287 as on 06 Apr, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cpc Diagnostics Private Limited
- Date of Incorporation 10 Jul, 1991
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$23.81 M (USD)34.64as on Mar 31, 2023
-
Net Profit
$1.38 M (USD)33.39as on Mar 31, 2023
-
EBITDA
$3.34 M (USD)53.98as on Mar 31, 2023
-
Total Equity Funding
$9.27 M (USD)
in 3 rounds
-
Latest Funding Round
$685.46 K (USD), Unspecified
Feb 08, 2021
- Investors
-
Employee Count
287
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CPC diagnostics
CPC diagnostics offers a comprehensive portfolio of products and services, including Biochemistry Products, Haematology Analyzer, and Immunology Products.
Reagents and instruments for biochemical testing in labs
Devices for blood cell counting and analysis
Tests for immune system disorders and infections
People of CPC diagnostics
Unlock access to complete
Funding Insights of CPC diagnostics
CPC diagnostics has successfully raised a total of $9.27M across 3 strategic funding rounds. The most recent funding activity was a Unspecified round of $685.46 thousand completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CPC diagnostics
CPC diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Everlife Asia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diagnostic and scientific solutions are provided for Asian markets.
|
Locked | Locked | Locked |
Investor details for CPC diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CPC diagnostics
Investment portfolio details for CPC diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CPC diagnostics
Detailed financials for CPC diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cpc Diagnostics Comparisons
Peer comparison for CPC diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CPC diagnostics
CPC diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Molecular diagnostic device and kits
|
|
| Locked | Locked | Locked |
Molecular biology reagents and kits are supplied for research applications.
|
|
| Locked | Locked | Locked |
Research services, reagents, and kits for biotech applications are provided.
|
|
| Locked | Locked | Locked |
Bioreagents and assay kits are developed, with preclinical services provided.
|
Detailed competitors of CPC diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cpc Diagnostics
Complete news archive for CPC diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CPC diagnostics
CPC diagnostics was founded in 1987 and raised its 1st funding round 31 years after it was founded.
CPC diagnostics is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Pramod Kabra is the current CEO of CPC diagnostics.
CPC diagnostics is a funded company, having raised a total of $9.27M across 3 funding rounds to date.
As of Apr 06, 2024, the latest employee count at CPC diagnostics is 287.
Annual revenue of CPC diagnostics is $23.81M as on Mar 31, 2023.
CPC Diagnostics was established in 1987 in Chennai, India, within the diagnostics sector. Instruments and reagents for chemistry, hematology, coagulation, immunoassays, and molecular diagnostics are supplied, along with pre-analytical automation products. Operations focus on supporting the clinical laboratory industry through these offerings. Leadership includes Pramod Kabra as CEO and Managing Director, and R Panchanath as Managing Director.
CPC diagnostics's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
CPC diagnostics offers Biochemistry Products, Haematology Analyzer, and Immunology Products.
CPC diagnostics has 1 investor. Key investors include Everlife Asia.
The valuation of CPC diagnostics is $21.41M as of Feb 2021.